![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 12, 2024 7:42:21 PM
Everyone has an “agenda”.
If yours is wanting to engage in “discussions, I suggest you circle back to this:
“Control of Postoperative Pain with a Wearable Continuously Operating Pulsed Radiofrequency Energy Device: A Preliminary Study
Ian M. Rawe, Adam Lowenstein, C. Raul Barcelo & David G. Genecov
BioElectronics RecoveryRx® was investigated in a double blind, randomized and placebo controlled study for postoperative pain and narcotic pain medication use following breast augmentation surgery. Data, VAS pain scores (0-10) and medication was collected for seven days post-surgery. The group using RecoveryRx® experienced 50% less pain and consumed significantly less narcotic pain medications. The study is published in the Aesthetics of Plastic Surgery.”
Scroll down to the second Study to find it here…
https://www.bielcorp.com/clinical-evidence/postoperative-pain-edema/“
Then, review your recent trashing posts, excuse me, “discussions”, of the Study which is directed at invalidating it, then peppered with your “discussion” of the “conflict of interest” by one the authors. You know, the Study which was published in the Aesthetics of Plastic Surgery and peer reviewed. Yeah, go toe to toe with the PhD’s who did the Study. Maybe the third time is the charm as I’ve mapped-out your “discussion” route twice! It ain’t with me.
You trash the Study and the authors…you go trash, excuse me, “discuss” with them, not me. Capische?
And then, for good measure, go toe to toe and “discuss” with the “Aesthetics of Plastic Surgery” for “allowing” this Study to be published based on your credentials (that we know not of).
Yes, go “discuss” with those two groups and get back to us.
What’s my “agenda” in this post. That there’s no fine line between “discussing” and “trashing”.
Another trading day gone and closer to 01 January 2025. Noisier day by the day. But I repeat myself.
No one knows what will happen. Not guaranteed to be a go, nor guaranteed to be a fail for BIEL. See how balanced that statement is?
“discussions” meh
All IMO.
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM